A drugs deal for the worlds poorest : now the fight over patents and cheap medicine is in middle- income countries
Since Novartis launched it cancer drug Glivec two years ago, it has been hailed as one of the biggest medical breakthrough from the pharmaceuticals industry in years. Glivec, which targets a rare